HB Wealth Management’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Other funds holding KRON
VVA
AI
WCM
TCM
SL
HB Wealth Management's KRON Position: Q4 2024 in Review
HB Wealth Management sold out of Kronos Bio (KRON) in Q4 2024, closing a stake of 27,500 shares — an estimated $27.5K sold.
HB Wealth Management first reported a position in KRON in Q3 2024 and held it in 1 quarter. The position peaked at $27.5K in Q3 2024. 56 funds tracked by Wall St. Rank hold KRON as of Q4 2024.
- HB Wealth Management reported no remaining Kronos Bio position as of Q4 2024 after selling out during the quarter.
- HB Wealth Management sold 27,500 Kronos Bio shares in Q4 2024, an estimated $27.5K.
- HB Wealth Management first reported a position in Kronos Bio in Q3 2024 and held it in 1 quarter.
- HB Wealth Management's Kronos Bio position peaked at $27.5K in Q3 2024.
- 56 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2024.
Based on HB Wealth Management's 13F filing for Q4 2024, filed 15 Jan 2025.